Document Detail

Cyclooxygenase-2 Expression in Urinary Bladder Transitional Cell Carcinoma and its Association with Clinicopathological Characteristics.
MedLine Citation:
PMID:  24083698     Owner:  NLM     Status:  Publisher    
Background: Transitional cell carcinoma (TCC) is the most predominant type of urinary bladder tumor. As cyclooxygenase (COX)-2 is recently introduced as an attractive target molecule in bladder TCC, we evaluated the immunohistochemical expression of this marker and its association with several clinicopathological characteristics. Materials and Methods: This cross-sectional study was performed in the Pathology department of Sina Hospital in Tehran, Iran during 2006-2011. Ninety-two paraffin embedded blocks were selected from patients with urinary bladder TCC who underwent cystectomy or transurethral resection (TUR). Then, we assessed COX-2 expression by immunohistochemical staining using antibody against COX-2. Staining in more than 5% of tumor cells was considered as positive expression. Results: COX-2 was expressed in 50 % of our patients. This marker was markedly expressed in high grade bladder TCC (62.1%) versus other grades and there was statistically a significant difference in COX-2 expression between various grades (p=0.008). In addition, patients' age, lymphatic and perineurial invasion were associated with the expression of COX-2 (p=0.001, 0.015 and 0.039, respectively). However, other parameters such as stage, tumor size, venous invasion and lymph node metastasis did not show any significant relationship with this marker (all, p>0.05). Conclusions: COX-2 was expressed in urinary bladder TCC especially in high grade forms, advocating its probable role in the differentiation of this tumor. Accordingly, COX-2 could be a valuable biological target molecule in the evaluation and treatment of patients with bladder TCC.
Hedieh Moradi Tabriz; Golrokh Olfati; Seyed Ali Ahmadi; Sudabeh Yusefnia
Related Documents :
10526048 - Laparoscopic resection of large leiomyomas of the gastric fundus.
20187018 - Intraoperative evaluation of bony margins with frozen-section analysis and trephine dri...
7619718 - Childhood ganglioglioma and medically intractable epilepsy. a clinicopathological study...
24356718 - Factors predicting clinical impairment after surgery for cervical spinal schwannoma.
10422778 - Possible participation of intracellular platelet-activating factor in tumor necrosis fa...
8330278 - Cytogenetic study of 249 consecutive patients examined for a bone tumor.
Publication Detail:
Journal Detail:
Title:  Asian Pacific journal of cancer prevention : APJCP     Volume:  14     ISSN:  1513-7368     ISO Abbreviation:  Asian Pac. J. Cancer Prev.     Publication Date:  2013  
Date Detail:
Created Date:  2013-10-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130625     Medline TA:  Asian Pac J Cancer Prev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  4539-4543     Citation Subset:  -    
Department of Pathology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran E-mail :
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Screening for MiRNAs Related to Laryngeal Squamous Carcinoma Stem Cell Radiation.
Next Document:  Pattern of Tissue Expression of CA-125 and HE4 in Primary Epithelial Ovarian Tumours and Correlation...